Kawasaki's disease;La maladie de Kawasaki

Annales de Dermatologie et de Venereologie

Volumn 128, Issue 6-7, 2001, Pages 773-782

  Rybojad, M ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; IMMUNOGLOBULIN;

ARTICLE; BACTERIAL INFECTION; CHEILITIS; DIFFERENTIAL DIAGNOSIS; HEMORRHAGIC CONJUNCTIVITIS; HUMAN; INFANT; INFANT DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHOTODERMATOSIS; PROGNOSIS; SYMPTOMATOLOGY; VASCULARIZATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ASPIRIN; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GAMMA-GLOBULINS; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 0034927035     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Acute febrile mucocutaneous lymph node syndrome: Clinical observations of 50 cases
2. Diagnostic guidelines for Kawasaki disease
3. Maladie de Kawasaki
4. The etiology and pathogenesis of Kawasaki disease-how close are we to answer?
5. Kawasaki disease
6. Adult Kawasaki syndrome
7. Adult Kawasaki disease
8. Le syndrome de Kawasaki chez l'adulte
9. Characterisation of T cell repertoire changes in acute Kawasaki disease
10. La maladie de Kawasaki
11. Toxic shock syndrom toxin-secreting Staphylococcus aureus in Kawasaki syndrome
12. Endothelial cell activation and high Interleukin-1 secretion in the pathogenesis of acute Kawasaki disease
13. Diagnostic and management of Kawasaki disease
14. Manifestations cutanées de la maladie de Kawasaki. A propos de 30 observations
15. Etude prospective de 64 cas de maladie de Kawasaki
16. Kawasaki disease in infants less than one year of age
17. Kawasaki Syndrome
18. Kawasaki disease
19. Clinical aspects of 100 patients with Kawasaki Disease
20. Atypical Kawasaki disease: Analysis of clinical presentation and diagnostic clues
21. The perineal eruption of Kawasaki syndrome
22. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease
23. Facial palsy in Kawasaki disease, Report of two cases and a review
24. Renal manifestations of Kawasaki's disease
25. Acute febrile mucocutaneous lymph node syndrome
26. Kawasaki disease: Effect of treatment on coronary artery involvement
27. Mortality rates For patients with a history of Kawasaki disease in Japon
28. Summary and abstracts of the sixth international Kawasaki disease symposium
29. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease
30. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease
31. Association of rug shampooing and Kawasaki disease
32. Polymerase activity in lymphocyte culture supernatants From patients with Kawasaki disease
33. Seroprevalence of human herpesvirus 7 in patients with Kawasaki disease
34. Human parvovirus B19 infection in Kawasaki disease
35. Kawasaki disease, Epstein-Barr virus and coronary artery aneurysms
36. Immunological findings in Kawasaki disease: An evaluation in a cohort of Italian children
37. Mycoplasme infection and Kawasaki
38. Variant strain of Propionibacterium acnes: A clue to the aetiology of Kawasaki disease
39. Epstein-Barr virus and other Herpesvirus infections in Kawasaki syndrome
40. Recurrence of Kawasaki disease and Epstein-Barr virus infection
41. Association of Rotavirus infection with Kawasaki syndrome
42. Recurrent Kawasaki disease associated with co-infection with parvovirus B19 and HIV-1
43. Active or recent parvovirus B19 infection in children with Kawasaki disease
44. Human herpesvirus 6 infection and Kawasaki disease
45. Ehrlichia chaffensis and Rochalimea Antibodies in Kawasaki disease
46. Retrovirus serology and Kawasaki syndrome
47. Group A sreptococcal infection and Kawasaki syndrome
48. Does Kawasaki disease have a retroviral etiology?
49. Kawasaki associated with HIV infection
50. Human parvovirus B19 infection in Kawasaki disease
51. Toxic shock syndrom toxin-secreting Staphylococcus aureus in Kawasaki syndrome
52. Sequente of the Toxic shock syndrom toxin gene (tst H) borne by strains of Staphylococcus aureus isolated From patients with Kawasaki syndrome
53. Superantigens in the aetiology of Kawasaki disease
54. Evidence for Superantigen involvement in cardiovascular injury due to Kawasaki Syndrome
55. TCR Vβ family repertoire and T cell activation markers in Kawasaki disease
56. Clonal expansion of CD8+ cells in Kawasaki disease
57. Thetreatment of Kawasaki syndrome with intravenous Gamma Globulin
58. A single intravenous infusion of gammaglobulin as compared with four infusions in the treatment of acute Kawasaki syndrome
59. Treatment of Kawasaki disease
60. Plasma exchange in Kawasaki Disease
61. The prevention of coronary artery aneurysm in Kawasaki Disease: A meta-analysis on the efficacy of aspirin and immunoglobin treatment
62. A trial procedure to prevent aneurysm formation of the coronary arteries by steroids pulse therapy in kawasaki disease
63. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids
64. Treatment of kawasaki disease: Corticosteroids revisited
65. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease